PUNE, India, March 28, 2016 /PRNewswire/ --
New market research titled "Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H2 2015" provides an overview of the Peripheral Neuropathy's therapeutic pipeline. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Company Profiles discussed in this report includes Arcturus Therapeutics, Inc, aTyr Pharma, Inc., GeNeuro SA, INSYS Therapeutics, Inc., Mitsubishi Tanabe Pharma Corporation, Neuren Pharmaceuticals Limited, Pfizer Inc., Polyneuron Pharmaceuticals AG, RegeneRx Biopharmaceuticals, Inc. and Teijin Pharma Limited. Complete report on H2 2015 pipeline review of Peripheral Neuropathy with 30 market data tables and 13 figures, spread across 78 pages is available at http://www.rnrmarketresearch.com/peripheral-neuropathy-sensory-neuropathy-pipeline-review-h2-2015-market-report.html
Drugs Profiles discussed in this report includes (immune globulin (human) + hyaluronidase (recombinant)), Cannabidiol, fingolimod hydrochloride, GL-2045, immune globulin (human), LUNAR-102, Monoclonal Antibody for CIDP, NNZ-2591, Peptide to Activate GLP1R for CNS, Metabolic Disorders and Head Trauma, Peptides to Activate GLP-1 Receptor for CNS Disorders and Head Trauma, PN-1007, Proteins for Inflammation, Hematological, Metabolic, Oncology, Neurodegenerative and Cardiovascular Disorder, RGN-352 and Synthetic Peptides for Peripheral Neuropathy.
Order a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=414328
This report provides comprehensive information on the therapeutic development for Peripheral Neuropathy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Peripheral Neuropathy and special features on late-stage and discontinued projects.
Scope of this report: The report provides a snapshot of the global therapeutic landscape of Peripheral Neuropathy. The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities and also key players involved in the therapeutics development for Peripheral Neuropathy and enlists all their major and minor projects summarizing all the dormant and discontinued pipeline projects. A review of the Peripheral Neuropathy products under development by companies and universities/research institutes based on information derived from company and industry-specific sources, pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages, detailed assessment of monotherapy and combination therapy pipeline projects, coverage of the Peripheral Neuropathy pipeline on the basis of target, MoA, route of administration and molecule type and latest news and deals relating related to pipeline products.
Another newly published market research report titled Warts - Pipeline Review, H2 2015 provides comprehensive information on the therapeutic development for Warts, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Warts and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Warts Pipeline market research report of 91 pages is available at http://www.rnrmarketresearch.com/warts-pipeline-review-h2-2015-market-report.html
Explore more reports on Therapeutics.
About Us:
RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel: +1-888-391-5441
sales@rnrmarketresearch.com
Connect with Us:
G+ / Google Plus: https://plus.google.com/104156468549256253075/posts
Twitter: https://twitter.com/RnRMR
Facebook: https://www.facebook.com/pages/RnR-Market-Research/413488545356345
